Press ReleasesJanuary 6, 2025•4 min read

Thyroid Function Test Market size worth US$1,797.005 million by 2030

Key Highlights

The global thyroid function test market is expected to reach a value of US$1,797.005 million by 2030, growing at a CAGR of 2.70%. It is valued at US$979.259 million in 2025. The thyroid function test or TFT is a process of quantitation of thyroid stimulating hormone (TSH) along w...

The global thyroid function test market is expected to reach a value of US$1,797.005 million by 2030, growing at a CAGR of 2.70%. It is valued at US$979.259 million in 2025. The thyroid function test or TFT is a process of quantitation of thyroid stimulating hormone (TSH) along with circulating thyroid hormones in serum, which assesses the functionality of the thyroid gland. The thyroid function test helps in diagnosing multiple conditions like hyperthyroidism, Graves' disease, thyroid cancer, and Hashimoto's disease among others. The increasing global cases of thyroid cancer are estimated to boost the global thyroid function test market during the forecasted timeline. The Macmillan Cancer Support, in its report, stated that in the UK, around 3,500 individuals are diagnosed each year.

  • Growth Drivers in Thyroid Function Test Market

With the increasing global cases of thyroid-related diseases across the globe, the demand for the thyroid function test market is expected to witness significant growth. Various global pharmaceutical and healthcare leaders across the globe have introduced key products and solutions for thyroid function tests. For instance, in February 2023, Parkway Laboratories, a global leader in accurate medical tests and analytical equipment, announced that the company had added Thyroid Screen in Pregnancy into its portfolio.

  • Segmentation of the Thyroid Function Test Market

The type segment of the thyroid function test market is categorized into thyroid stimulating hormone tests, T4 tests, T3 tests, and others. In the type segment of the global thyroid function test market, the thyroid stimulating hormone tests category is estimated to attain a greater market share during the forecasted timeline. Thyroid stimulating hormone tests or TSH are a type of thyroid function test, which helps in analyzing the functionality of the thyroid gland. The thyroid stimulating hormone tests help in detecting the level of hyperthyroidism and hypothyroidism in the blood of the individual. The test also helps in the condition of heart & digestive functions, and muscle control. By indication, the thyroid function test market is segmented into hypothyroidism, hyperthyroidism, thyroid cancer, and others. The thyroid cancer category under the indication segment of the thyroid function test market is expected to grow significantly. The global cases of thyroid witnessed massive growth over the years. Thyroid cancer is among the most common types of cancer, prevalent across both genders. The American Cancer Society, in its report, stated that in the USA, the probability of thyroid cancer in males between the ages of 0 and 49 years was recorded at 1 in 457 total cancer cases, whereas in females in the same age group was recorded at 1 in 125 total cancer cases. By end-users, the thyroid function test market is segmented into hospitals and clinics, diagnostic centers, and others. The diagnostic centers category in the global end-user segment of the thyroid function test market is expected to witness rapid growth. The diagnostic center is a type of medical facility, which offers diagnostic tests and procedures performed to diagnose multiple types of health conditions and diseases. The diagnostic centers also help by offering regular medical checkups and providing accurate diagnostic results. Based on geography, the North American region is expected to witness significant growth in the global thyroid function test market. The North American region is among the most developed and technologically advanced in the healthcare sector, offering continuous investments in the sector. Various countries in the region, like the USA and Canada, have introduced key policies and investment schemes to boost the integration of new technologies into the pharmaceutical and healthcare sector, which is expected to boost the efficiency of thyroid function tests.

  • Key Players in the Thyroid Function Test Market

As a part of the report, the major players operating in the thyroid function test market that have been covered are Abbott, Randox Laboratories Ltd, bioMérieux SA, Thermo Fisher, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qualigen Inc., Beckman Coulter, Inc., and Quidel Corporation. View a sample of the report or purchase the complete study at: https://www.knowledge-sourcing.com/report/global-thyroid-function-test-market
  • By Type
    • Thyroid Stimulating Hormone Test
    • T4 Tests
    • T3 Tests
    • Others
  • By Indication
    • Hypothyroidism
    • Hyperthyroidism
    • Thyroid Cancer
    • Others
  • By End Users
    • Hospitals and clinics
    • Diagnostic centers
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • Spain
      • France
      • Others
    • Middle East and Africa
      • UAE
      • Saudi Arabia
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others
  • Endocrine Testing Market Report
  • Global Coagulation Testing Market Size
  • Thyroid Ablation Devices Market Report

Have questions?

More Press Releases

Aug 5, 2026

Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031

The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.

Click here to read→
Jul 30, 2026

Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%

The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.

Click here to read→
Jul 24, 2026

Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031

The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.

Click here to read→